E16.3 - Increased secretion of glucagon
- Applicable to Increased secretion of glucagon
- The 2025 edition of ICD10-CM E16.3 became effective on October 1, 2024.
- This is the American ICD10-CM version of E16.3 - other international versions of ICD10 E16.3 may differ.
- E16.3 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Hyperplasia of pancreatic endocrine cells with glucagon excess
Billable/Specific Code
The following codes above E16.3 contain annotation back-references that may be applicable to E16.3:
- Chapter: E00-E89 - Endocrine, nutritional and metabolic diseases
- Section: E15-E16 - Other disorders of glucose regulation and pancreatic internal secretion
- Category: E16 - Other disorders of pancreatic internal secretion
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com